Benzodiazepine

Benzodiazepines are psychoactive drugs that enhance signaling at GABA type A receptors. They are used chiefly for anxiety, insomnia, seizures, and muscle spasms, with effects and risks shaped by dose and duration.

GABA type A receptor: A ligand-gated ion channel that mediates much of the brain’s fast inhibitory signaling through gamma-aminobutyric acid. Benzodiazepines bind a modulatory site on this receptor and strengthen GABA’s inhibitory effect.
Anxiolytic: A drug or treatment that reduces anxiety. Benzodiazepines can rapidly relieve acute anxiety, though they are generally not preferred for long-term treatment.
Benzodiazepine dependence: A state in which the body adapts to benzodiazepines, so stopping or reducing them can cause withdrawal symptoms. Dependence can develop during regular use, including use at prescribed doses.
Barbiturate: A class of central nervous system depressants that enhance GABA type A receptor activity and can cause profound respiratory suppression. Barbiturates share a broad inhibitory target but have a narrower safety margin and different receptor effects.
Gamma-aminobutyric acid: The principal inhibitory neurotransmitter in the adult mammalian central nervous system. Benzodiazepines amplify signaling initiated by this neurotransmitter rather than replacing it.
Positive allosteric modulator: A substance that binds a protein at a site distinct from its main activating site and increases its response. This is the pharmacological role benzodiazepines play at GABA type A receptors.
Hypnotic: A drug that induces or supports sleep. Some benzodiazepines are prescribed for short-term insomnia because they promote sleep and reduce arousal.
Benzodiazepine withdrawal syndrome: A set of symptoms caused by reducing or stopping benzodiazepines after the body has adapted to them. Abrupt discontinuation can cause severe symptoms, including seizures; gradual tapering is often used.
Z-drug: A nonbenzodiazepine sedative-hypnotic, such as zolpidem, that acts at benzodiazepine-sensitive GABA type A receptors. Z-drugs are often prescribed for insomnia but are chemically distinct and share several risks with benzodiazepines.
Allosteric regulation: Regulation of a protein’s activity through binding at a site separate from its primary functional site. Benzodiazepines alter receptor responses through allosteric binding instead of directly opening the channel.

Linked from 53 pages